Rani Therapeutics Holdings Inc (NASDAQ:RANI) traded at $0.7 at close of the session on Monday, July 14 and made an upward move of 8.45% on its previous day’s price.
Looking at the stock we see that its previous close was $0.64 and the beta (5Y monthly) reads -0.0 with the day’s price range being $0.56 – $0.8658. In terms of its 52-week price range, RANI has a high of $4.19 and a low of $0.46. The company’s stock has gained about 21.95% over that past 30 days.
Rani Therapeutics Holdings Inc has a market cap of $44.15 million and is expected to release its quarterly earnings report on 2025-May-13.
On the other hand, looking at the outlook for the RANI stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell.
Based on estimates by 3 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Rani Therapeutics Holdings Inc (RANI) stock as a Hold, while 3 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 26.69% off its SMA20 and 11.23% from its 50-day simple moving average. The RSI (14) is pointing at 65.70 while the volatility over the past week is 20.55% and jumps to 9.84% over the past one month. The average price target for the stock over the next 12 months is $10, with the estimates having a low of $9 and a high of $28. These price ends are -1185.71% and -3900.0% off the current price level respectively, although investors could be excited at the prospect of a -1328.57% if the RANI share price touches on the median price of $10.
Coming back to Rani Therapeutics Holdings Inc (NASDAQ:RANI), we note that the average 3-month trading volume was 476.12K, while that of the preceding 10-day period stands at 6.45 million. Current shares outstanding are 33.57 million.
The insiders hold 32.10% of the company’s shares while institutions hold 6.28%. The data shows that short shares as of 2025-06-13, stood at 3.63 million at a short ratio of 4.68. This represents a 1530.00 short interest in shares outstanding on 2025-06-13. Shares short rose in June from the previous month at 2.94 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -78.77% down in year-to-date price movement.
